118 related articles for article (PubMed ID: 31770527)
1. Ferrocenes as new anticancer drug candidates: Determination of the mechanism of action.
Skoupilova H; Bartosik M; Sommerova L; Pinkas J; Vaculovic T; Kanicky V; Karban J; Hrstka R
Eur J Pharmacol; 2020 Jan; 867():172825. PubMed ID: 31770527
[TBL] [Abstract][Full Text] [Related]
2. Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research.
Ge X; Chen S; Liu X; Wang Q; Gao L; Zhao C; Zhang L; Shao M; Yuan XA; Tian L; Liu Z
Inorg Chem; 2019 Oct; 58(20):14175-14184. PubMed ID: 31559820
[TBL] [Abstract][Full Text] [Related]
3. The Antiproliferative Activity of Ferrocene Derivatives against Drug- Resistant Cancer Cell Lines: A Mini Review.
Li L; Ma L; Sun J
Curr Top Med Chem; 2021; 21(19):1756-1772. PubMed ID: 34323188
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy.
Ren SZ; Wang ZC; Zhu D; Zhu XH; Shen FQ; Wu SY; Chen JJ; Xu C; Zhu HL
Eur J Med Chem; 2018 Sep; 157():909-924. PubMed ID: 30149323
[TBL] [Abstract][Full Text] [Related]
5. 10
Zhang J; Ming C; Zhang W; Okechukwu PN; Morak-Młodawska B; Pluta K; Jeleń M; Akim AM; Ang KP; Ooi KK
Drug Des Devel Ther; 2017; 11():3045-3063. PubMed ID: 29123378
[TBL] [Abstract][Full Text] [Related]
6. Ferrocenes as potential chemotherapeutic drugs: synthesis, cytotoxic activity, reactive oxygen species production and micronucleus assay.
Pérez WI; Soto Y; Ortíz C; Matta J; Meléndez E
Bioorg Med Chem; 2015 Feb; 23(3):471-9. PubMed ID: 25555734
[TBL] [Abstract][Full Text] [Related]
7. Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships.
Wang R; Chen H; Yan W; Zheng M; Zhang T; Zhang Y
Eur J Med Chem; 2020 Mar; 190():112109. PubMed ID: 32032851
[TBL] [Abstract][Full Text] [Related]
8. The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin.
Rogalska A; Gajek A; Szwed M; Jóźwiak Z; Marczak A
Toxicol In Vitro; 2011 Dec; 25(8):1712-20. PubMed ID: 21896327
[TBL] [Abstract][Full Text] [Related]
9. Novobiocin-ferrocene conjugates possessing anticancer and antiplasmodial activity independent of HSP90 inhibition.
Mbaba M; de la Mare JA; Sterrenberg JN; Kajewole D; Maharaj S; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
J Biol Inorg Chem; 2019 Mar; 24(2):139-149. PubMed ID: 30542925
[TBL] [Abstract][Full Text] [Related]
10. Activation by Oxidation: Ferrocene-Functionalized Ru(II)-Arene Complexes with Anticancer, Antibacterial, and Antioxidant Properties.
Mu C; Prosser KE; Harrypersad S; MacNeil GA; Panchmatia R; Thompson JR; Sinha S; Warren JJ; Walsby CJ
Inorg Chem; 2018 Dec; 57(24):15247-15261. PubMed ID: 30495936
[TBL] [Abstract][Full Text] [Related]
11. Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like Cells.
González-Bártulos M; Aceves-Luquero C; Qualai J; Cussó O; Martínez MA; Fernández de Mattos S; Menéndez JA; Villalonga P; Costas M; Ribas X; Massaguer A
PLoS One; 2015; 10(9):e0137800. PubMed ID: 26368127
[TBL] [Abstract][Full Text] [Related]
12. Electrochemical analysis of a novel ferrocene derivative as a potential antitumor drug.
Bartošík M; Koubková L; Karban J; Červenková Šťastná L; Hodík T; Lamač M; Pinkas J; Hrstka R
Analyst; 2015 Sep; 140(17):5864-7. PubMed ID: 26203467
[TBL] [Abstract][Full Text] [Related]
13. Iron containing anti-tumoral agents: unexpected apoptosis-inducing activity of a ferrocene amino acid derivative.
Kater B; Hunold A; Schmalz HG; Kater L; Bonitzki B; Jesse P; Prokop A
J Cancer Res Clin Oncol; 2011 Apr; 137(4):639-49. PubMed ID: 20544219
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological effect of aminoferrocene in mice with L1210 leukemia.
Chekhun VF; Mokhir A; Daum S; Todor IN; Lukianova NY; Shvets YV; Burlaka AP
Exp Oncol; 2015 Jun; 37(2):120-5. PubMed ID: 26112939
[TBL] [Abstract][Full Text] [Related]
15. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.
Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I
J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153
[TBL] [Abstract][Full Text] [Related]
16. New ferrocene-based 2-thio-imidazol-4-ones and their copper complexes. Synthesis and cytotoxicity.
Guk DA; Krasnovskaya OO; Dashkova NS; Skvortsov DA; Rubtsova MP; Dyadchenko VP; Yudina ES; Kosarev MA; Soldatov AV; Shapovalov VV; Semkina AS; Vlasova KY; Pergushov VI; Shafikov RR; Moiseeva AA; Andreeva AV; Andreeva AA; Melnikov MY; Zyk NV; Majouga AG; Beloglazkina EK
Dalton Trans; 2018 Dec; 47(48):17357-17366. PubMed ID: 30480670
[TBL] [Abstract][Full Text] [Related]
17. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
18. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
Peter S; Aderibigbe BA
Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298
[TBL] [Abstract][Full Text] [Related]
19. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the mechanism and apoptotic pathway induced by 4β cinnamido linked podophyllotoxins against human lung cancer cells A549.
Kamal A; Nayak VL; Bagul C; Vishnuvardhan MV; Mallareddy A
Apoptosis; 2015 Nov; 20(11):1518-29. PubMed ID: 26386574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
